{"pmid":32387139,"title":"A dual-centre observational review of hospital based palliative care in patients dying with COVID-19.","text":["A dual-centre observational review of hospital based palliative care in patients dying with COVID-19.","The current Covid-19 pandemic has put significant strain on all aspects of healthcare delivery, including palliative care services. Given the high mortality from this disease, particularly in the more vulnerable members of society, it is important to examine how best to deliver a high standard of end of life care during this crisis. This case series collected data from two acute hospitals examining the management of patients diagnosed with Covid-19 who subsequently died (n=36) and compared this to national and local end of life audit data for all other deaths. Our results demonstrated a shorter dying phase (38.25 hours vs 74 hours) and higher rates of syringe driver use (72% vs 33% in local audits), although with similar average mediation doses. Of note was the significant heterogeneity in the phenotype of deterioration in the dying phase, two distinct patterns emerged, with one group demonstrating severe illness with a short interval between symptom onset and death and another group presenting with a more protracted deterioration. This brief report suggests a spectrum of mode of dying. Over all the cohort reflects previously described experiences, with increased frailty (median Clinical Frailty Scale score of 5) and extensive comorbidity burden. This brief report provides clinicians with a contemporaneous overview of our experience, knowledge and pattern recognition when caring for people with Covid-19 and highlights the value of proactive identification of patients and risk of deterioration and palliation.","J Pain Symptom Manage","Turner, Jennifer","Eliot Hodgson, Luke","Leckie, Todd","Eade, Lisa","Ford-Dunn, Suzanne","32387139"],"abstract":["The current Covid-19 pandemic has put significant strain on all aspects of healthcare delivery, including palliative care services. Given the high mortality from this disease, particularly in the more vulnerable members of society, it is important to examine how best to deliver a high standard of end of life care during this crisis. This case series collected data from two acute hospitals examining the management of patients diagnosed with Covid-19 who subsequently died (n=36) and compared this to national and local end of life audit data for all other deaths. Our results demonstrated a shorter dying phase (38.25 hours vs 74 hours) and higher rates of syringe driver use (72% vs 33% in local audits), although with similar average mediation doses. Of note was the significant heterogeneity in the phenotype of deterioration in the dying phase, two distinct patterns emerged, with one group demonstrating severe illness with a short interval between symptom onset and death and another group presenting with a more protracted deterioration. This brief report suggests a spectrum of mode of dying. Over all the cohort reflects previously described experiences, with increased frailty (median Clinical Frailty Scale score of 5) and extensive comorbidity burden. This brief report provides clinicians with a contemporaneous overview of our experience, knowledge and pattern recognition when caring for people with Covid-19 and highlights the value of proactive identification of patients and risk of deterioration and palliation."],"journal":"J Pain Symptom Manage","authors":["Turner, Jennifer","Eliot Hodgson, Luke","Leckie, Todd","Eade, Lisa","Ford-Dunn, Suzanne"],"date":"2020-05-11T11:00:00Z","year":2020,"_id":"32387139","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.jpainsymman.2020.04.031","keywords":["covid-19","end of life care","frailty","palliative care","symptom management"],"topics":["Prevention"],"weight":1,"_version_":1666428892765749248,"score":9.490897,"similar":[{"pmid":32325167,"pmcid":"PMC7169932","title":"Characteristics, symptom management and outcomes of 101 patients with COVID-19 referred for hospital palliative care.","text":["Characteristics, symptom management and outcomes of 101 patients with COVID-19 referred for hospital palliative care.","Hospital palliative care is an essential part of the COVID-19 response but data are lacking. We identified symptom burden, management, response to treatment, and outcomes for a case series of 101 in-patients with confirmed COVID-19 referred to hospital palliative care. Patients (64 male, median [IQR] age 82 [72-89] years, Elixhauser Comorbidity Index 6 [2-10], Australian-modified Karnofsky Performance Status 20 [10-20]), were most frequently referred for end of life care or symptom control. Median [IQR] days from hospital admission to referral was 4 [1-12] days. Most prevalent symptoms (n) were breathlessness (67), agitation (43), drowsiness (36), pain (23) and delirium (24). Fifty-eight patients were prescribed a subcutaneous infusion. Frequently used medicines (median-maximum dose/24h) were opioids (morphine, 10-30mg; fentanyl, 100-200mcg; alfentanil 500-1000 mcg) and midazolam (10-20mg). Infusions were assessed as at least partially effective for 40/58 patients, while 13 patients died before review. Patients spent a median [IQR] of 2 [1-4] days under the palliative care team, who made 3 [2-5] contacts across patient, family and clinicians. At March 30 2020, 75 patients had died, 13 been discharged back to team, home or hospice, and 13 continued to receive inpatient palliative care. Palliative care is an essential component to the COVID-19 response, and teams must rapidly adapt with new ways of working. Breathlessness and agitation are common but respond well to opioids and benzodiazepines. Availability of subcutaneous infusion pumps is essential. An international minimum dataset for palliative care would accelerate finding answers to new questions as the COVID-19 pandemic develops.","J Pain Symptom Manage","Lovell, Natasha","Maddocks, Matthew","Etkind, Simon N","Taylor, Katie","Carey, Irene","Vora, Vandana","Marsh, Lynne","Higginson, Irene J","Prentice, Wendy","Edmonds, Polly","Sleeman, Katherine E","32325167"],"abstract":["Hospital palliative care is an essential part of the COVID-19 response but data are lacking. We identified symptom burden, management, response to treatment, and outcomes for a case series of 101 in-patients with confirmed COVID-19 referred to hospital palliative care. Patients (64 male, median [IQR] age 82 [72-89] years, Elixhauser Comorbidity Index 6 [2-10], Australian-modified Karnofsky Performance Status 20 [10-20]), were most frequently referred for end of life care or symptom control. Median [IQR] days from hospital admission to referral was 4 [1-12] days. Most prevalent symptoms (n) were breathlessness (67), agitation (43), drowsiness (36), pain (23) and delirium (24). Fifty-eight patients were prescribed a subcutaneous infusion. Frequently used medicines (median-maximum dose/24h) were opioids (morphine, 10-30mg; fentanyl, 100-200mcg; alfentanil 500-1000 mcg) and midazolam (10-20mg). Infusions were assessed as at least partially effective for 40/58 patients, while 13 patients died before review. Patients spent a median [IQR] of 2 [1-4] days under the palliative care team, who made 3 [2-5] contacts across patient, family and clinicians. At March 30 2020, 75 patients had died, 13 been discharged back to team, home or hospice, and 13 continued to receive inpatient palliative care. Palliative care is an essential component to the COVID-19 response, and teams must rapidly adapt with new ways of working. Breathlessness and agitation are common but respond well to opioids and benzodiazepines. Availability of subcutaneous infusion pumps is essential. An international minimum dataset for palliative care would accelerate finding answers to new questions as the COVID-19 pandemic develops."],"journal":"J Pain Symptom Manage","authors":["Lovell, Natasha","Maddocks, Matthew","Etkind, Simon N","Taylor, Katie","Carey, Irene","Vora, Vandana","Marsh, Lynne","Higginson, Irene J","Prentice, Wendy","Edmonds, Polly","Sleeman, Katherine E"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32325167","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jpainsymman.2020.04.015","keywords":["covid-19","coronavirus","end of life","hospice","palliative care","symptom management"],"locations":["Australian"],"countries":["Australia"],"countries_codes":["AUS|Australia"],"e_drugs":["Morphine","Fentanyl","Benzodiazepines","Midazolam","Alfentanil"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138493917593600,"score":263.67108},{"pmid":32454184,"title":"Development of a Palliative Care Toolkit for the COVID-19 Pandemic.","text":["Development of a Palliative Care Toolkit for the COVID-19 Pandemic.","The COVID-19 pandemic has led to high numbers of critically ill and dying patients in need of expert management of dyspnea, delirium, and serious illness communication. The rapid spread of SARS-CoV-2 creates surges of infected patients requiring hospitalization and puts palliative care programs at risk of being overwhelmed by patients, families, and clinicians seeking help. In response to this unprecedented need for palliative care, our program sought to create a collection of palliative care resources for non-palliative care clinicians. A workgroup of interdisciplinary palliative care clinicians developed the Palliative Care Toolkit, consisting of a detailed chapter in a COVID-19 online resource, a mobile and desktop web application, one-page guides, pocket cards, and communication skills training videos. The suite of resources provides expert and evidence-based guidance on symptom management including dyspnea, pain, and delirium, and also on serious illness communication, including conversations about goals of care, code status, and end-of-life. We also created a nurse resource hotline staffed by palliative care nurse practitioners and virtual office hours staffed by a palliative care attending physician. Since its development, the Toolkit has helped us disseminate best practices to non-palliative care clinicians delivering primary palliative care, allowing our team to focus on the highest-need consults, and increasing acceptance of palliative care across hospital settings.","J Pain Symptom Manage","Thomas, Jane deLima","Leiter, Richard E","Abrahm, Janet L","Shameklis, Jaclyn C","Kiser, Stephanie B","Gelfand, Samantha L","Sciacca, Kate R","Reville, Barbara","Siegert, Callie A","Zhang, Haipeng","Lai, Lucinda","Sato, Rintaro","Smith, Lorie N","Kamdar, Mihir M","Greco, Lauren","Lee, Kathleen A","Tulsky, James A","Lawton, Andrew J","32454184"],"abstract":["The COVID-19 pandemic has led to high numbers of critically ill and dying patients in need of expert management of dyspnea, delirium, and serious illness communication. The rapid spread of SARS-CoV-2 creates surges of infected patients requiring hospitalization and puts palliative care programs at risk of being overwhelmed by patients, families, and clinicians seeking help. In response to this unprecedented need for palliative care, our program sought to create a collection of palliative care resources for non-palliative care clinicians. A workgroup of interdisciplinary palliative care clinicians developed the Palliative Care Toolkit, consisting of a detailed chapter in a COVID-19 online resource, a mobile and desktop web application, one-page guides, pocket cards, and communication skills training videos. The suite of resources provides expert and evidence-based guidance on symptom management including dyspnea, pain, and delirium, and also on serious illness communication, including conversations about goals of care, code status, and end-of-life. We also created a nurse resource hotline staffed by palliative care nurse practitioners and virtual office hours staffed by a palliative care attending physician. Since its development, the Toolkit has helped us disseminate best practices to non-palliative care clinicians delivering primary palliative care, allowing our team to focus on the highest-need consults, and increasing acceptance of palliative care across hospital settings."],"journal":"J Pain Symptom Manage","authors":["Thomas, Jane deLima","Leiter, Richard E","Abrahm, Janet L","Shameklis, Jaclyn C","Kiser, Stephanie B","Gelfand, Samantha L","Sciacca, Kate R","Reville, Barbara","Siegert, Callie A","Zhang, Haipeng","Lai, Lucinda","Sato, Rintaro","Smith, Lorie N","Kamdar, Mihir M","Greco, Lauren","Lee, Kathleen A","Tulsky, James A","Lawton, Andrew J"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32454184","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.jpainsymman.2020.05.021","topics":["Prevention"],"weight":1,"_version_":1667881798450806785,"score":230.70955},{"pmid":32384004,"title":"Systems Barriers to Assessment and Treatment of COVID-19 Positive Patients at the End of Life.","text":["Systems Barriers to Assessment and Treatment of COVID-19 Positive Patients at the End of Life.","The Novel Coronavirus SARS-CoV-2 (COVID-19) pandemic is changing how we deliver expert palliative care. We can expect many to die prematurely secondary to COVID-19 across the United States. We present a case of how several hospital systems-based interventions, intended to slow viral spread and to protect health care workers, have inadvertently created barriers to routine palliative interventions in this patient population. Isolation of patients, limitation of visitors and interdisciplinary support, and changes in nursing and provider assessment have all had their impact on how we deliver palliative care. These barriers have altered many aspects of our established workflow and algorithms for care, including changes in communication, goals of care discussions, how providers and nurses are monitoring for symptoms, and end-of-life monitoring. These challenges required real-time solutions such as technology utilization, proposing a change in medical delivery systems, and reducing redundancy to preserve personal protective equipment. To continue to deliver quality care for this patient population, palliative medicine must adapt quickly.","J Palliat Med","Pahuja, Meera","Wojcikewych, Devon","32384004"],"abstract":["The Novel Coronavirus SARS-CoV-2 (COVID-19) pandemic is changing how we deliver expert palliative care. We can expect many to die prematurely secondary to COVID-19 across the United States. We present a case of how several hospital systems-based interventions, intended to slow viral spread and to protect health care workers, have inadvertently created barriers to routine palliative interventions in this patient population. Isolation of patients, limitation of visitors and interdisciplinary support, and changes in nursing and provider assessment have all had their impact on how we deliver palliative care. These barriers have altered many aspects of our established workflow and algorithms for care, including changes in communication, goals of care discussions, how providers and nurses are monitoring for symptoms, and end-of-life monitoring. These challenges required real-time solutions such as technology utilization, proposing a change in medical delivery systems, and reducing redundancy to preserve personal protective equipment. To continue to deliver quality care for this patient population, palliative medicine must adapt quickly."],"journal":"J Palliat Med","authors":["Pahuja, Meera","Wojcikewych, Devon"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32384004","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1089/jpm.2020.0190","keywords":["covid-19","palliative care","patient isolation","symptom assessment","symptom management","system barriers"],"locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666419683263250432,"score":223.91133},{"pmid":32467101,"title":"Symptom burden and clinical profile of COVID-19 deaths: a rapid systematic review and evidence summary.","text":["Symptom burden and clinical profile of COVID-19 deaths: a rapid systematic review and evidence summary.","The spread of pandemic COVID-19 has created unprecedented need for information. The pandemic is the cause of significant mortality and with this the need for rapidly disseminated information for palliative care professionals regarding the prevalence of symptoms, their intensity, their resistance or susceptibility to symptom control and the mode of death for patients. METHODS: We undertook a systematic review of published evidence for symptoms in patients with COVID-19 (with a specific emphasis on symptoms at end of life) and on modes of death. Inclusion: prospective or retrospective studies detailing symptom presence and/or cause or mode of death from COVID-19. RESULTS: 12 papers met the inclusion criteria and gave details of symptom burden: four of these specifically in the dying and two detailed the cause or mode of death. Cough, breathlessness, fatigue and myalgia are significant symptoms in people hospitalised with COVID-19. Dyspnoea is the most significant symptom in the dying. The mode of death was described in two papers and is predominantly through respiratory or heart failure. CONCLUSIONS: There remains a dearth of information regarding symptom burden and mode of death to inform decisions regarding end-of-life care in patients dying with COVID-19. Rapid data gathering on the mode of death and the profile of symptoms in the dying and their prevalence and severity in areas where COVID-19 is prevalent will provide important intelligence for clinicians. This should be done urgently, within ethical norms and the practicalities of a public health, clinical and logistical emergency.","BMJ Support Palliat Care","Keeley, Paul","Buchanan, Deans","Carolan, Clare","Pivodic, Lara","Tavabie, Simon","Noble, Simon","32467101"],"abstract":["The spread of pandemic COVID-19 has created unprecedented need for information. The pandemic is the cause of significant mortality and with this the need for rapidly disseminated information for palliative care professionals regarding the prevalence of symptoms, their intensity, their resistance or susceptibility to symptom control and the mode of death for patients. METHODS: We undertook a systematic review of published evidence for symptoms in patients with COVID-19 (with a specific emphasis on symptoms at end of life) and on modes of death. Inclusion: prospective or retrospective studies detailing symptom presence and/or cause or mode of death from COVID-19. RESULTS: 12 papers met the inclusion criteria and gave details of symptom burden: four of these specifically in the dying and two detailed the cause or mode of death. Cough, breathlessness, fatigue and myalgia are significant symptoms in people hospitalised with COVID-19. Dyspnoea is the most significant symptom in the dying. The mode of death was described in two papers and is predominantly through respiratory or heart failure. CONCLUSIONS: There remains a dearth of information regarding symptom burden and mode of death to inform decisions regarding end-of-life care in patients dying with COVID-19. Rapid data gathering on the mode of death and the profile of symptoms in the dying and their prevalence and severity in areas where COVID-19 is prevalent will provide important intelligence for clinicians. This should be done urgently, within ethical norms and the practicalities of a public health, clinical and logistical emergency."],"journal":"BMJ Support Palliat Care","authors":["Keeley, Paul","Buchanan, Deans","Carolan, Clare","Pivodic, Lara","Tavabie, Simon","Noble, Simon"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32467101","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1136/bmjspcare-2020-002368","keywords":["hospital care","symptoms and symptom management","terminal care"],"topics":["Diagnosis"],"weight":1,"_version_":1668167109917540353,"score":207.7673},{"pmid":32437942,"title":"International COVID-19 palliative care guidance for nursing homes leaves key themes unaddressed.","text":["International COVID-19 palliative care guidance for nursing homes leaves key themes unaddressed.","COVID-19 mortality disproportionally affects nursing homes, creating enormous pressures to deliver high-quality end-of-life care. Comprehensive palliative care should be an explicit part of both national and global COVID-19 response plans. Therefore, we aimed to identify, review and compare national and international COVID-19 guidance for nursing homes concerning palliative care, issued by government bodies and professional associations. We performed a directed documentary and content analysis of newly developed or adapted COVID-19 guidance documents from across the world. Documents were collected via expert consultation and independently screened against pre-specified eligibility criteria. We applied thematic analysis and narrative synthesis techniques. We identified 21 eligible documents covering both nursing homes and palliative care; from the World Health Organization (n=3), and eight individual countries: USA (n=7), the Netherlands (n=2), Ireland (n=1), United Kingdom (n=3), Switzerland (n=3), New Zealand (n=1), Belgium (n=1). International documents focused primarily on infection prevention and control, including only a few sentences on palliative care related topics. Palliative care themes most frequently mentioned across documents were end-of-life visits, advance care planning documentation, and clinical decision-making towards the end of life (focusing on hospital transfers). There is a dearth of comprehensive international COVID-19 guidance on palliative care for nursing homes. Most have a limited focus both regarding breadth of topics and recommendations made. Key aspects of palliative care, i.e. symptom management, staff education and support, referral to specialist services or hospice, and family support, need greater attention in future guidelines.","J Pain Symptom Manage","Joni, Gilissen","Lara, Pivodic","Unroe Kathleen, T","Lieve, Van den Block","32437942"],"abstract":["COVID-19 mortality disproportionally affects nursing homes, creating enormous pressures to deliver high-quality end-of-life care. Comprehensive palliative care should be an explicit part of both national and global COVID-19 response plans. Therefore, we aimed to identify, review and compare national and international COVID-19 guidance for nursing homes concerning palliative care, issued by government bodies and professional associations. We performed a directed documentary and content analysis of newly developed or adapted COVID-19 guidance documents from across the world. Documents were collected via expert consultation and independently screened against pre-specified eligibility criteria. We applied thematic analysis and narrative synthesis techniques. We identified 21 eligible documents covering both nursing homes and palliative care; from the World Health Organization (n=3), and eight individual countries: USA (n=7), the Netherlands (n=2), Ireland (n=1), United Kingdom (n=3), Switzerland (n=3), New Zealand (n=1), Belgium (n=1). International documents focused primarily on infection prevention and control, including only a few sentences on palliative care related topics. Palliative care themes most frequently mentioned across documents were end-of-life visits, advance care planning documentation, and clinical decision-making towards the end of life (focusing on hospital transfers). There is a dearth of comprehensive international COVID-19 guidance on palliative care for nursing homes. Most have a limited focus both regarding breadth of topics and recommendations made. Key aspects of palliative care, i.e. symptom management, staff education and support, referral to specialist services or hospice, and family support, need greater attention in future guidelines."],"journal":"J Pain Symptom Manage","authors":["Joni, Gilissen","Lara, Pivodic","Unroe Kathleen, T","Lieve, Van den Block"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32437942","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.jpainsymman.2020.04.151","keywords":["covid-19","long-term care","nursing homes","palliative care"],"locations":["Netherlands","Ireland","United Kingdom","Switzerland","New Zealand","Belgium"],"countries":["Ireland","New Zealand","Belgium","Netherlands","Switzerland","United Kingdom"],"countries_codes":["IRL|Ireland","NZL|New Zealand","BEL|Belgium","NLD|Netherlands","CHE|Switzerland","GBR|United Kingdom"],"topics":["Prevention"],"weight":1,"_version_":1667521393779015680,"score":207.07344}]}